World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
18499
World Ranking
19842
National Ranking
1783

Michael Laffan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael Laffan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 337 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael Laffan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Laffan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 72 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael Laffan is affiliated with Imperial College London in the United Kingdom. Their research activity is primarily situated within the field of Medicine, with a significant focus on Hematology. Other subfields include Internal Medicine, Surgery, Infectious Diseases, and Genetics.

Their research covers a variety of specialized topics centered on blood disorders and related clinical conditions. Key areas of work are:

  • Platelet Disorders and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • COVID-19 Clinical Research Studies
  • Hemophilia Treatment and Research
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Blood Coagulation and Thrombosis Mechanisms
  • COVID-19 and healthcare impacts

Michael Laffan has contributed to multiple publications in journals that frequently feature their research. Notable venues include:

  • British Journal of Haematology
  • Journal of Thrombosis and Haemostasis
  • Research and Practice in Thrombosis and Haemostasis
  • Blood
  • Haemophilia

Frequent collaborators in their research encompass:

  • Deepa J. Arachchillage
  • Indika Rajakaruna
  • Nicola Curry
  • Richard Szydlo
  • Zain Odho

Among recent papers associated with Michael Laffan are:

  • Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, 2021, New England Journal of Medicine
  • Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, 2020, Journal of Thrombosis and Haemostasis
  • Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A, 2020, New England Journal of Medicine
  • ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease, 2021, Blood Advances
  • COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects, 2021, Angiogenesis

Best Publications

  • Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity

    Simone Wahl;Alexander Drong;Benjamin Lehne;Marie Loh;Marie Loh;Marie Loh

  • AAV5–Factor VIII Gene Transfer in Severe Hemophilia A

    Savita Rangarajan;Liron Walsh;Will Lester;David Perry

  • Endothelial von Willebrand factor regulates angiogenesis

    Richard D. Starke;Francesco Ferraro;Koralia E. Paschalaki;Nicola H. Dryden

  • Whole-genome sequencing of patients with rare diseases in a national health system.

    E Turro;W J Astle;W J Astle;K Megy;S Gräf

  • Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A

    K John Pasi;Savita Rangarajan;Nina Mitchell;Will Lester

  • The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology

    Mike A. Laffan;Will Lester;James S. O'Donnell;Andrew Will

  • Whole-genome sequencing of patients with rare diseases in a national health system

    Ernest Turro;William J Astle;Karyn Megy;Stefan Graf

  • The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.

    J. O'Donnell;M. A. Laffan

  • Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

    Deepa R. J. Arachchillage;Deepa R. J. Arachchillage;Mike Laffan;Mike Laffan

  • Transcriptional diversity during lineage commitment of human blood progenitors

    Lu Chen;Lu Chen;Lu Chen;Myrto Kostadima;Myrto Kostadima;Myrto Kostadima;Joost H. A. Martens;Giovanni Canu;Giovanni Canu

  • High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.

    J O’Donnell;E G D Tuddenham;R Manning;G Kemball-Cook

  • Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality

    Amit Patel;Amit Patel;Michael A Laffan;Umeer Waheed;Stephen J Brett

  • Elevation of FVIII : C in Venous Thromboembolism Is Persistent and Independent of the Acute Phase Response

    James O'Donnell;Andrew D. Mumford;Richard A. Manning;Michael Laffan

  • Guideline on the management of bleeding in patients on antithrombotic agents.

    Mike Makris;Joost J Van Veen;Campbell R Tait;Andrew D Mumford

  • Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis

    Andrew D. Mumford;James O'donnell;Julian D. Gillmore;Richard A. Manning

  • The Use of Fresh-Frozen Plasma in England: High Levels of Inappropriate Use in Adults and Children

    Simon J. Stanworth;John Grant-Casey;Derek Lowe;Mike Laffan

  • The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

    M. Laffan;S. A. Brown;Peter William Collins;A. M. Cumming

  • Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial.

    P Chowdary;S Lethagen;S Lethagen;U Friedrich;B Brand

  • Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction.

    E. Mercuri;F. Cowan;G. Gupte;R. Manning

  • ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.

    Nathan T. Connell;Veronica H. Flood;Romina Brignardello-Petersen;Rezan Abdul-Kadir

Frequent Co-Authors

Willem H. Ouwehand
Willem H. Ouwehand University of Cambridge
Jonathan Stephens
Jonathan Stephens University of Cambridge
David Lane
David Lane Imperial College London
Timothy J. Aitman
Timothy J. Aitman University of Edinburgh
Peter Collins
Peter Collins Cardiff University
Simon J. Stanworth
Simon J. Stanworth NHS Blood and Transplant
Dorian O. Haskard
Dorian O. Haskard Imperial College London
Rémi Favier
Rémi Favier University of Paris-Saclay
Daniel F. Cutler
Daniel F. Cutler University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA often begins with nursing or related pathways before applying to medical school. Many students opt for online degrees due to their flexibility and lower cost. Those just starting might consider cheapest bsn programs online to earn a Bachelor of Science in Nursing affordably, which provides a solid foundation for advanced studies or direct patient care.

If you’re a registered nurse seeking career advancement, the rn to bsn online cost is an important consideration. RN to BSN programs expand your clinical knowledge and open more doors for leadership responsibilities.

For those looking to further specialize or enter academia, an online phd nursing offers the chance to engage in advanced research or teaching roles, all while balancing current work obligations.

Non-nurses interested in advanced practice can explore direct entry np programs for non nurses online, which provide a unique pathway toward becoming a nurse practitioner. These programs allow career changers to swiftly transition into nursing and advanced practice roles.

Each online pathway caters to different career goals within healthcare, making it easier than ever to start or advance your medical education online.

Best Scientists Citing Michael Laffan

Trending Scientists

Recently Published Articles